About ForCare Clinical Research
Clinical Trials at ForCare Clinical Research
During the past decade, ForCare Clinical Research conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 25 clinical trials were completed, i.e. on
average, 39.7% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 25 clinical trials were completed. i.e. 80.6%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "ForCare Clinical Research" #1 sponsor was "Eli Lilly and Company" with 29 trials, followed by "Pfizer" with 18 trials
sponsored, "Incyte Corporation" with 3 trials sponsored, "Concert Pharmaceuticals" with 2 trials sponsored and "RAPT Therapeutics, Inc."
with 2 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ForCare Clinical Research"
#1 collaborator was "Incyte Corporation" with 7 trials as a collaborator, "Dermira, Inc." with 5 trials as a collaborator, "Nektar Therapeutics" with 2 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at ForCare Clinical Research
According to Clinical.Site data, the most researched conditions in "ForCare Clinical Research" are
"Atopic Dermatitis" (17 trials), "Alopecia Areata" (6 trials), "Psoriasis" (6 trials), "Dermatitis, Atopic" (5 trials) and "Migraine" (4 trials). Many other conditions were trialed in "ForCare Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at ForCare Clinical Research
Most popular intervention types in "ForCare Clinical Research" are "Drug" (57 trials), "Biological" (8 trials), "Other" (7 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (38 trials), "Baricitinib" (7 trials), "Lebrikizumab" (6 trials), "PF-04965842 100 mg" (3 trials) and "PF-04965842 200 mg" (3 trials). Other intervention names were less common.
Clinical Trials Genders at ForCare Clinical Research
The vast majority of trials in "ForCare Clinical Research" are
63 trials for "All" genders.
Clinical Trials Status at ForCare Clinical Research
Currently, there are NaN active trials in "ForCare Clinical Research".
undefined are not yet recruiting,
14 are recruiting,
10 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 28 completed trials in ForCare Clinical Research,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in ForCare Clinical Research, 7 "Phase 1"
clinical trials were conducted, 21 "Phase 2" clinical
trials and 35 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 0 trials that are defined as “Not Applicable".